Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Interneuron licenses U.S. rights to urinary incontinence treatment

Nov. 30, 1999

VPA-985: PK/PD of novel aquaretic agent examined in CHF patients

Nov. 25, 1999

Merck's new PDE5 inhibitors useful for impotence, cardiovascular disorders

Nov. 24, 1999

Pfizer's portfolio includes new early-stage compounds for MED

Nov. 23, 1999

Anthranilic acid derivatives from Fujisawa particularly useful for erectile dysfunction

Nov. 22, 1999

Chronic oral treatment with SR-121463 improves water retention in cirrhotic rats

Nov. 16, 1999

VPA-985 as a novel treatment option for hyponatremia in cirrhosis: clinical results

Nov. 15, 1999

Preclinical data reported at ASN support utility of OP-1 in treating renal disease

Nov. 12, 1999

Novel agents for renal diseases with benzimidazole structure

Nov. 11, 1999

NeXstar research leads to identification of new target for treating renal disease

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...